Status:
UNKNOWN
Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
Lead Sponsor:
Peking University People's Hospital
Conditions:
Rabies
Eligibility:
All Genders
20-60 years
Phase:
PHASE4
Brief Summary
This study is to investigate the persistence of rabies Chinese manufactured antibody 1-5 years after the post-exposure prophylaxis with vero cell antirabies vaccine and antibody response to a single b...
Eligibility Criteria
Inclusion
- 20 to 60 years old
- Healthy
- Given ChengDa rabies vaccine
- Good compliance
- Obtained informed consent
Exclusion
- Other than inclusion criteria
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01173302
Start Date
May 1 2010
End Date
September 1 2010
Last Update
August 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044